Tag Archives: SARS-CoV-2

05Apr/20

Alternatives to Cope with Lengthy Clinical Development Process for COVID-19

April 5, 2020News, Recombinant Antibody R&DClinical Development, SARS-CoV-2, therapeutic antibodybiorab

The latest update— Cases of COVID-19 in the U.S. at a Glance on April 3, 2020, which include both confirmed and presumptive positive cases of COVID-19 reported to CDC or tested atRead More…

19Feb/20

Focus on SARS-CoV-2

February 19, 2020Recombinant Antibody R&DCoronavirus, COVID-19, SARS-CoV-2biorab

As we all know, a new crown pneumonia epidemic suddenly swept China at the end of 2019 and even affected the whole world. On January 30, 2020, WHO announced that the epidemicRead More…

Therapeutic Antibody R&D
Recombinant Antibody R&D
Antibody Engineering R&D
News